Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2011 (2011), Article ID 934757, 8 pages
http://dx.doi.org/10.1155/2011/934757
Research Article

Development of a Serum Biomarker Assay That Differentiates Tumor-Associated MUC5AC (NPC-1C ANTIGEN) from Normal MUC5AC

Neogenix Oncology, Inc., 9700 Great Seneca Highway, Suite 262, Rockville, MD 20850, USA

Received 24 September 2010; Accepted 16 November 2010

Academic Editor: Kwong Yok Tsang

Copyright © 2011 Janos Luka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Cancer Society, Cancer Fact & Figures 2009, American Cancer Society, Atlanta, 2009.
  2. E. P. Dimagno, H. A. Reber, and M. A. Tempero, “AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma,” Gastroenterology, vol. 117, no. 6, pp. 1464–1484, 1999. View at Google Scholar · View at Scopus
  3. W. Steinberg, “The clinical utility of the CA 19-9 tumor-associated antigen,” American Journal of Gastroenterology, vol. 85, no. 4, pp. 350–355, 1990. View at Google Scholar · View at Scopus
  4. R. Lamerz, “Role of tumour markers, cytogenetics,” Annals of Oncology, vol. 10, supplement 4, pp. S145–S149, 1999. View at Google Scholar · View at Scopus
  5. G. Y. Locker, S. Hamilton, J. Harris et al., “ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer,” Journal of Clinical Oncology, vol. 24, no. 33, pp. 5313–5327, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. D. K. Rex, D. A. Johnson, J. C. Anderson, P. S. Schoenfeld, C. A. Burke, and J. M. Inadomi, “American college of gastroenterology guidelines for colorectal cancer screening 2008,” American Journal of Gastroenterology, vol. 104, no. 3, pp. 739–750, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Hollinshead, D. Glew, B. Bunnag, P. Gold, and R. Herberman, “Skin-reactive soluble antigen from intestinal cancer-cell-membranes and relationship to carcinoembryonic antigens,” Lancet, vol. 1, no. 7658, pp. 1191–1195, 1970. View at Google Scholar · View at Scopus
  8. A. C. Hollinshead, C. G. Mcwright, T. C. Alford, D. H. Glew, P. Gold, and R. B. Herberman, “Separation of skin reactive intestinal cancer antigen from the carcinoembryonic antigen of gold,” Science, vol. 177, no. 4052, pp. 887–889, 1972. View at Google Scholar · View at Scopus
  9. A. Hollinshead, E. G. Elias, and M. Arlen, “Specific active immunotherapy in patients with adenocarcinoma of the colon utilizing tumor-associated antigens (TAA). A phase I clinical trial,” Cancer, vol. 56, no. 3, pp. 480–489, 1985. View at Google Scholar · View at Scopus
  10. M. A. Hollingsworth and B. J. Swanson, “Mucins in cancer: protection and control of the cell surface,” Nature Reviews Cancer, vol. 4, no. 1, pp. 45–60, 2004. View at Google Scholar · View at Scopus
  11. B. B. Haab, A. Porter, T. Yue et al., “Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms,” Annals of Surgery, vol. 251, no. 5, pp. 937–945, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Han, V. Pansare, M. Al-Abbadi, M. Husain, and J. Feng, “Combination of MUC5ac and WT-1 immunohistochemistry is useful in distinguishing pancreatic ductal carcinoma from ovarian serous carcinoma in effusion cytology,” Diagnostic Cytopathology, vol. 38, no. 5, pp. 333–336, 2010. View at Publisher · View at Google Scholar
  13. J. Bara, R. Gautier, and N. Daher, “Monoclonal antibodies against oncofetal mucin M1 antigens associated with precancerous colonic mucosae,” Cancer Research, vol. 46, no. 8, pp. 3983–3989, 1986. View at Google Scholar
  14. J. Bara, R. Gautier, J. Le Pendu, and R. Oriol, “Immunochemical characterization of mucins. Polypeptide (M1) and polysaccharide (A and Le(b)) antigens,” Biochemical Journal, vol. 254, no. 1, pp. 185–193, 1988. View at Google Scholar · View at Scopus
  15. J. Bara, R. Gautier, P. Mouradian, C. Decaens, and N. Daher, “Oncofetal mucin M1 epitope family: characterization and expression during colonic carcinogenesis,” International Journal of Cancer, vol. 47, no. 2, pp. 304–310, 1991. View at Google Scholar · View at Scopus
  16. C. A. Reis, L. David, P. A. Nielsen et al., “Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody,” International Journal of Cancer, vol. 74, no. 1, pp. 112–121, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Nollet, M. E. Forgue-Lafitte, P. Kirkham, and J. Bara, “Mapping of two new epitopes on the apomucin encoded by MUC5AC gene: expression in normal GI tract and colon tumors,” International Journal of Cancer, vol. 99, no. 3, pp. 336–343, 2002. View at Publisher · View at Google Scholar · View at Scopus